Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus.

Tuan Dinh LeNga Thi Phi NguyenSon Tien NguyenHoa Thi Thanh TranLan Thi Ho NguyenHoang Huy DuongHa Manh NguyenNhu Binh Do

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)

Sitagliptin improved beta-cell function, insulin resistance and blood glucose in newly diagnosed patients with T2D. Meanwhile, Sitagliptin ameliorated serum GLP-1 concentrations, which contributed to the enhancement of beta-cell.

Keyphrases

newly diagnosed
blood glucose
insulin resistance
end stage renal disease
chronic kidney disease
adipose tissue
single cell
metabolic syndrome
cell therapy
blood pressure